Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in:

01-05-2014 | Original Paper

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

Auteurs: Luc Lecavalier, Jeffrey J. Wood, Alycia K. Halladay, Nancy E. Jones, Michael G. Aman, Edwin H. Cook, Benjamin L. Handen, Bryan H. King, Deborah A. Pearson, Victoria Hallett, Katherine Anne Sullivan, Sabrina Grondhuis, Somer L. Bishop, Joseph P. Horrigan, Geraldine Dawson, Lawrence Scahill

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 5/2014

Abstract

Despite the high rate of anxiety in individuals with autism spectrum disorder (ASD), measuring anxiety in ASD is fraught with uncertainty. This is due, in part, to incomplete consensus on the manifestations of anxiety in this population. Autism Speaks assembled a panel of experts to conduct a systematic review of available measures for anxiety in youth with ASD. To complete the review, the panel held monthly conference calls and two face-to-face meetings over a fourteen-month period. Thirty eight published studies were reviewed and ten assessment measures were examined: four were deemed appropriate for use in clinical trials, although with conditions; three were judged to be potentially appropriate, while three were considered not useful for clinical trials assessing anxiety. Despite recent advances, additional relevant, reliable and valid outcome measures are needed to evaluate treatments for anxiety in ASD.

vorige artikel Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development

volgende artikel Exploring Perceptual Skills in Children with Autism Spectrum Disorders: From Target Detection to Dynamic Perceptual Discrimination

Alleen toegankelijk voor geautoriseerde gebruikers

Achenbach, T. M. (1991). Manual for the child behavior checklist/4-18 and 1991 profile. Burlington, VT: University of Vermont, Department of Psychiatry.

Achenbach, T. M. (2005). Advancing assessment of children and adolescents: Commentary on evidence-based assessment of child and adolescent disorders. Journal of Clinical Child and Adolescent Psychology, 34(3), 541–547. PubMedCrossRef

Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA school-age forms and profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families.

Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. American Journal of Psychiatry, 159(8), 1337–1346.

Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist—A behavior rating-scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485–491. PubMed

Aman, M. G., Tasse, M. J., Rojahn, J., & Hammer, D. (1996). The Nisonger CBRF: A child behavior rating form for children with developmental disabilities. Research in Developmental Disabilities, 17, 41–57. PubMedCrossRef

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revised). Washington, DC: American Psychiatric Association.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association.

Barmish, A. J., & Kendall, P. C. (2005). Should parents be co-clients in cognitive-behavioral therapy for anxious youth? Journal of Clinical Child and Adolescent Psychology, 34(3), 569–581. PubMedCrossRef

Birmaher, B., Brent, D. A., Chiapetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): A replication study. Journal of the American Academy of Child and Adolescent Psychiatry, 38(10), 1230–1236. PubMedCrossRef

Birmaher, B., Khetarpal, S., Brent, D., Cully, M., Balach, L., Kaufman, J., et al. (1997). The screen for child anxiety related emotional disorders (SCARED): Scale construction and psychometric characteristics. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 545–553. PubMedCrossRef

Cartwright-Hatton, S., McNally, D., Field, A. P., Rust, S., Laskey, B., Dixon, C., et al. (2011). A new parenting-based group intervention for young anxious children: Results of a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 50(3), 242–251.e6. PubMedCrossRef

Centers for Disease Control and Prevention. (2012). Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 61, Number 3.

Centre for Childhood Disability Research. (2004). Outcome measures rating form guidelines. www.canchild.ca. Accessed March 19, 2013.

Chalfant, A. M., Rapee, R., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Developmental Disorders, 37(10), 1842–1857. PubMedCrossRef

Chorpita, B. F., Moffitt, C. E., & Gray, J. A. (2005). Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample. Behaviour Research and Therapy, 43, 309–322. PubMedCrossRef

Chorpita, B. F., & Nakamura, B. J. (2008). Dynamic structure in diagnostic structured interviewing: A comparative test of accuracy and efficiency. Journal of Psychopathology and Behavioral Assessment, 30, 52–60. CrossRef

Chorpita, B. F., Yim, L. M., Moffitt, C. E., Umemoto, L. A., & Francis, S. E. (2000). Assessment of symptoms of DSM-IV anxiety and depression in children: A Revised Child Anxiety and Depression Scale. Behaviour Research and Therapy, 38, 835–855. PubMedCrossRef

Costello, E. J., Egger, H. L., & Angold, A. (2005). The developmental epidemiology of anxiety disorders: Phenomenology, prevalence, and comorbidity. Child and Adolescent Psychiatric Clinics of North America, 14(4), 631–648, vii.

Curry, J. F., & Craighead, W. E. (1990). Attributional style in clinically depressed and conduct disordered adolescents. Journal of Consulting and Clinical Psychology, 58, 109–115. PubMedCrossRef

Dierker, L. C., Albano, A. M., Clarke, G. N., Heimberg, R. G., Kendall, P. C., Merikangas, K. R., et al. (2001). Screening for anxiety and depression in early adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40(8), 929–936. PubMedCrossRef

Diggle, P. J., Heagerty, P., Liang, K.-Y., & Zeger, S. L. (2002). Analysis of Longitudinal Data (2nd ed.). Oxford: Oxford University Press.

Dutra, L., Campbell, L., & Westen, D. (2004). Quantifying clinical judgment in the assessment of adolescent psychopathology: Reliability, validity, and factor structure of the child behavior checklist for clinician report. Journal of Clinical Psychology, 60(1), 65–85. PubMedCrossRef

Ebesutani, C., Bernstein, A., Nakamura, B. J., Chopita, B. F., Higa-McMillan, C. K., & Weisz, J. R. (2010). Concurrent validity of the child behavior checklist DSM-oriented scales: Correspondence with DSM diagnoses and comparison to syndrome scales. Journal of Psychopathology and Behavioural Assessment, 32(3), 373–384. CrossRef

Esbensen, A. J., Rojahn, J., Aman, M. G., & Ruedrich, S. (2003). Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders, 33(6), 617–629. PubMedCrossRef

Evans, D. W., Canavera, K., Kleinpeter, F. L., Maccubbin, E., & Taga, K. (2005). The fears, phobias and anxieties of children with autism spectrum disorders and down syndrome: Comparisons with developmentally and chronologically age matched children. Child Psychiatry and Human Development, 36(1), 3–26. PubMedCrossRef

Fischbach, G. D., & Lord, C. (2010). The Simons simplex collection: A resource for identification of autism genetic risk factors. Neuron, 68(2), 192–195. PubMedCrossRef

Fleiss, J. L., Levin, B., & Paik, M. C. (2003). Satistical methods for rates and proportions. Wiley series in probability and statistics (3rd ed.). Hoboken, NJ: Wiley-Interscience. CrossRef

Fombonne, E. (2009). The epidemiology of pervasive developmental disorders. Pediatric Research, 65(6), 591–598. PubMedCrossRef

Gadow, K. D., Devincent, C. J., Pomeroy, J., & Azizian, A. (2005). Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism: The International Journal of Research and Practice, 9(4), 392–415. CrossRef

Gadow, K. D., & Sprafkin, J. (2002). Child symptom inventory-4 screening and norms manual. Stony Brook, NY: Checkmate Plus.

Ginsburg, G. S., Keeton, C. P., Drazdowski, T. K., & Riddle, M. A. (2011b). The utility of clinicians ratings of anxiety using the Pediatric Anxiety Rating Scale (PARS). Child and Youth Care Forum 40(2), 93–105.

Ginsburg, G. S., Kendall, P. C., Sakolsky, D., Compton, S. N., Piacentini, J., Albano, A. M., et al. (2011a). Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS. Journal of Consulting and Clinical Psychology, 79(6), 806. PubMedCentralPubMedCrossRef

Gotham, K., Bishop, S. L., Hus, V., Huerta, M., Lund, S., Buja, A., et al. (2012). Exploring the relationship between anxiety and insistence on sameness in autism spectrum disorders. Autism Research, 6(1), 33–41.

Grills, A. E., & Ollendick, T. H. (2003). Multiple informant agreement and the anxiety disorders interview schedule for parents and children. Journal of the American Academy of Child and Adolescent Psychiatry, 42(1), 30–40.

Grondhuis, S. N., & Aman, M. G. (2012). Assessment of anxiety in children and adolescents with autism spectrum disorders. Research in Autism Spectrum Disorders, 6(4), 1345–1365. CrossRef

Hallett, V., Lecavalier, L., Sukhodolsky, D. G., Cipriano, N., Aman, M. G., McCracken, J. T., et al. (2013a). Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. [Epub ahead of print].

Hallett, V., Ronald, A., Colvert, E., Ames, C., Woodhouse, E., Lietz, S., et al. (2013b). Exploring anxiety symptoms in a large-scale twin study of children with autism spectrum disorders, their co-twins and controls. Journal of Child Psychology and Psychiatry, 54, 1176–1185.

Hallett, V., Ronald, A., Rijsdijk, F., & Eley, T. C. (2009). Phenotypic and genetic differentiation of anxiety-related behaviors in middle childhood. Depression and Anxiety, 26(4), 316–324. PubMedCrossRef

Hallett, V., Ronald, A., Rijsdijk, F., & Happé, F. (2010). Association of autistic-like and internalizing traits during childhood: A longitudinal twin study. American Journal of Psychiatry, 167(7), 809–817. PubMedCrossRef

Kerns, C. M., & Kendall, P. C. (2012). The presentation and classification of anxiety in autism spectrum disorder. Clinical Psychology: Science and Practice, 19(4), 323–347.

King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583–590. PubMedCrossRef

Laughren, T. P. (2003). Comorbid mood disorders and medical illness: A Food and Drug Administration perspective. Biological Psychiatry, 54(3), 195–199. PubMedCrossRef

Laughren, T., & Levin, R. (2006). Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim. Schizophrenia Bulletin, 32(2), 220–222. PubMedCentralPubMedCrossRef

Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36(8), 1101–1114. PubMedCrossRef

Lecavalier, L., Aman, M. G., Hammer, D., Stoica, W., & Matthews, G. (2004). Factor Analysis of the Nisonger Child Behavior Rating Form in Children with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders, 34, 709–721. PubMedCrossRef

LeDoux, J. (1998). Fear and the brain: Where have we been, and where are we going? Biological Psychiatry, 44(12), 1229–1238. PubMedCrossRef

Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., et al. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7), 849–861. PubMedCrossRef

March, J. S., Parker, J. D., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 554–565. PubMedCrossRef

Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48(11), 1110–1119. PubMedCrossRef

Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York, NY: McGraw-Hill.

Perrin, S., & Last, C. G. (1992). Do childhood anxiety measures measure anxiety? Journal of Abnormal Child Psychology, 20, 567–578. PubMedCrossRef

Reaven, J., Blakeley-Smith, A., Culhane-Shelburne, K., & Hepburn, S. (2012). Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. Journal of Child Psychology and Psychiatry, 53(4), 410–419. PubMedCrossRef

Reaven, J., Blakeley-Smith, A., Nichols, S., Dasari, M., Flanigan, E., & Hepburn, S. (2009). Cognitive behavioral group treatment for anxiety symptoms in children with high functioning autism spectrum disorders: A pilot study. Focus on Autism and Other Developmental Disabilities, 24, 27–37.

Renno, P., & Wood, J. (in press). Discriminant and convergent validity of the anxiety construct in children with autism spectrum disorders. Journal of Autism and Developmental Disorders.

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347(5), 314–321. CrossRef

Research Units on Pediatric Psychopharmacology Anxiety Study Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344, 1279–1285. CrossRef

Research Units on Pediatric Psychopharmacology Anxiety Study Group. (2002). The pediatric anxiety rating scale (PARS): Development and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1061–1069. CrossRef

Research Units on Pediatric Psychopharmacology Autism Network. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62(11), 1266–1274. CrossRef

Reynolds, C. R., & Richmond, B. O. (1978). What I think and feel: A revised measure of child’s manifest anxiety. Journal of Abnormal Child Psychology, 6, 271–280. PubMedCrossRef

Silverman, W. K., & Albano, A. M. (1996). Anxiety disorders interview schedule for DSM-IV. Oxford: Oxford University Press.

Silverman, W. K., Saavedra, L. M., & Pina, A. A. (2001). Test–retest reliability of anxiety symptoms and diagnoses with the anxiety disorders interview schedule for DSM-IV: Child and parent versions. Journal of the American Academy of Child and Adolescent Psychiatry, 40(8), 937–944. PubMedCrossRef

Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921–929. PubMedCrossRef

Snyder, R., Turgay, A., Aman, M. G., Binder, C., Fisman, S., Carroll, A., et al. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1026–1036. PubMedCrossRef

Storch, E. A., Arnold, E. B., Lewin, A. B., Nadeau, J. M., Jones, A. M., De Nadai, A. S., et al. (2013). The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 52(2), 132–142. PubMedCrossRef

Storch, E. A., Ehrenreich, J., Wood, J. J., Jones, A. M., De Nadai, A. S., Lewin, A. B., et al. (2012b). Multiple informant agreement on the anxiety disorders interview schedule for youth with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 22(4), 292–299.

Storch, E. A., Wood, J. J., Ehrenreich May, J., Lewin, A. B., Jones, A. M., Park, J. M., et al. (2012a). Convergent and divergent validity and reliability of the Pediatric Anxiety Rating Scale. Journal of Autism and Developmental Disorders, 42, 2374–2382. PubMedCrossRef

Su, L., Wang, K., Fan, F., Su, Y., & Gao, X. (2008). Reliability and validity of the screen for child anxiety related emotional disorders (SCARED) in Chinese children. Journal of Anxiety Disorders, 22(4), 612–621. PubMedCrossRef

Sukhodolsky, D. G., Scahill, L., Gadow, K. D., Arnold, L. E., Aman, M. G., McDougle, C. J., et al. (2008). Parent-rated anxiety symptoms in children with pervasive developmental disorders: Frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology, 36, 117–128. PubMedCrossRef

Thayler, N. S., Kazemi, E., & Wood, J. J. (2010). Measuring anxiety in youth with learning disabilities: Reliability and validity of the Multidimensional Anxiety Scale for Children (MASC). Child Psychiatry and Human Development, 41(5), 501–514. CrossRef

van Steensel, F. J., Bogels, S. M., & Perrin, S. (2011). Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. Clinical Child and Family Psychology Review, 14(3), 302–317.

Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766. PubMedCentralPubMedCrossRef

Weisbrot, D. M., Gadow, K. D., DeVincent, C. J., & Pomeroy, J. (2005). The presentation of anxiety in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15(3), 477–496. PubMedCrossRef

White, S. W., Ollendick, T., Albano, A. M., Oswald, D., Johnson, C., Southam-Gerow, M. A., et al. (2013). Randomized controlled trial: Multimodal anxiety and social skill intervention for adolescents with autism spectrum disorder. Journal of Autism and Developmental Disorders, 43(2), 382–394. PubMedCentralPubMedCrossRef

White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29(3), 216–229. PubMedCentralPubMedCrossRef

Wood, J. J., Drahota, A., Sze, K. M., Har, K., Chiu, A., & Langer, D. (2009a). Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. Journal of Child Psychology and Psychiatry, 50, 224–234. PubMedCrossRef

Wood, J. J., & Gadow, K. D. (2010). Exploring the nature and function of anxiety in youth with autism spectrum disorders. Clinical Psychology: Research and Practice, 17, 281–292.

Wood, J. J., McLeod, B., Piacentini, J. C., & Sigman, M. (2009b). One-year follow-up of family versus child CBT for anxiety disorders: Exploring the roles of child age and parental intrusiveness. Child Psychiatry and Human Development, 40, 301–316. PubMedCentralPubMedCrossRef

Wood, J. J., Piacentini, J. C., Bergman, R. L., McCracken, J., & Barrios, V. (2002). Concurrent validity of the anxiety disorders section of the anxiety disorders interview schedule for DSM-IV: Child and parent versions. Journal of Clinical Child and Adolescent Psychology, 31(3), 335–342. PubMedCrossRef

Titel: Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder
Auteurs: Luc Lecavalier
Jeffrey J. Wood
Alycia K. Halladay
Nancy E. Jones
Michael G. Aman
Edwin H. Cook
Benjamin L. Handen
Bryan H. King
Deborah A. Pearson
Victoria Hallett
Katherine Anne Sullivan
Sabrina Grondhuis
Somer L. Bishop
Joseph P. Horrigan
Geraldine Dawson
Lawrence Scahill
Publicatiedatum: 01-05-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 5/2014
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-013-1974-9

Bohn Stafleu van Loghum

Tip

Swipe om te navigeren naar een ander artikel

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2014

Postsecondary Pathways and Persistence for STEM Versus Non-STEM Majors: Among College Students with an Autism Spectrum Disorder

Brief Report: Fathers’ and Mothers’ Ratings of Behavioral and Emotional Problems in Siblings of Children with Autism Spectrum Disorder

Comprehensive Comparison of Self-administered Questionnaires for Measuring Quantitative Autistic Traits in Adults

Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder

The Reciprocal Relationship of ASD, ADHD, Depressive Symptoms and Stress in Parents of Children with ASD and/or ADHD

Erratum to: Exploring Perceptual Skills in Children with Autism Spectrum Disorders: From Target Detection to Dynamic Perceptual Discrimination